What Biomoneta Research does
Founded in 2014, Biomoneta Research operates in Clean Tech offering air sterilization solutions based on its globally patented ZeBox Technology. The company's air sterilizers efficiently isolate, trap, and kill a broad range of pathogens from free-flowing air using a blend of nanomaterials and power electronics. Biomoneta's products are designed for deployment in various controlled environments, including hospitals, clinics, and offices. The recent Covid-19 pandemic underscored the significance of infection prevention, and the company aims to contribute to saving lives and preventing pandemics through its innovative technology.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about Biomoneta Research yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.